Celsion’s GEN-1 Combined with Chemotherapy May Help Treat Advanced Ovarian Cancer

Celsion’s GEN-1 Combined with Chemotherapy May Help Treat Advanced Ovarian Cancer
Interim results of a clinical trial evaluating Celsion’s GEN-1 combined with preoperative chemotherapy to treat patients with advanced ovarian cancer were recently presented at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting. The Phase 1b OVATION study (NCT02480374) is a dose-escalating trial that is currently evaluating the safety and effectiveness of GEN-1 (injected into the peritoneum) combined with

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *